Literature DB >> 7785431

Autonomic dysfunction in pathologically confirmed multiple system atrophy and idiopathic Parkinson's disease--a retrospective comparison.

M Magalhães1, G K Wenning, S E Daniel, N P Quinn.   

Abstract

INTRODUCTION: Autonomic dysfunction (AD) can be a feature of both multiple system atrophy (MSA) and idiopathic Parkinson's disease (IPD), conditions that are frequently misdiagnosed in life. Most studies on AD in MSA and IPD are based on clinical cases without pathological verification.
MATERIAL AND METHODS: We retrospectively analysed AD in 135 pathologically confirmed cases of IPD and in 33 of MSA from the UK PD Society Brain Bank.
RESULTS: MSA started at a younger age than IPD (54.4 +/- 10.7 yrs versus 60.6 +/- 10.8 yrs), and AD began earlier in the course of the illness All MSA patients had some degree of AD in life whereas AD was absent in 24% of IPD patients. Although each of five autonomic domains was affected in variable numbers of IPD patients, AD in MSA generally involved more autonomic domains than in IPD, and to a more severe degree, in particular with regard to inspiratory stridor.
CONCLUSIONS: These results indicate that the presence of autonomic disturbance alone does not distinguish between MSA and IPD in individual cases. However, the presence of severe AD, of AD preceding parkinsonism, or of inspiratory stridor, are all individually suggestive of MSA.

Entities:  

Mesh:

Year:  1995        PMID: 7785431     DOI: 10.1111/j.1600-0404.1995.tb00414.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  24 in total

1.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson's disease.

Authors:  D E Riley; T C Chelimsky
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-01       Impact factor: 10.154

2.  Parkinson disease: treatment of the nonmotor symptoms of Parkinson disease.

Authors:  Werner Poewe
Journal:  Nat Rev Neurol       Date:  2010-08       Impact factor: 42.937

3.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

4.  Suppressed sympathetic skin response in Parkinson disease.

Authors:  T H Haapaniemi; J T Korpelainen; U Tolonen; K Suominen; K A Sotaniemi; V V Myllylä
Journal:  Clin Auton Res       Date:  2000-12       Impact factor: 4.435

5.  Prospective study of relevance of 123I-MIBG myocardial scintigraphy and clonidine GH test to distinguish Parkinson's disease and multiple system atrophy.

Authors:  C Alves Do Rego; I J Namer; C Marcel; F Lefebvre; O Lagha-Boukbiza; M Renaud; C Tranchant; M Anheim
Journal:  J Neurol       Date:  2018-06-28       Impact factor: 4.849

6.  Vasomotor regulation in patients with multiple system atrophy.

Authors:  Kazumasa Shindo; Mai Tsuchiya; Yuta Ichinose; Kishin Koh; Takanori Hata; Nobuo Yamashiro; Fumikazu Kobayashi; Takamura Nagasaka; Yoshihisa Takiyama
Journal:  J Neural Transm (Vienna)       Date:  2016-11-08       Impact factor: 3.575

7.  The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type.

Authors:  David J Lin; Katherine L Hermann; Jeremy D Schmahmann
Journal:  Cerebellum       Date:  2016-12       Impact factor: 3.847

8.  (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.

Authors:  S Orimo; E Ozawa; S Nakade; T Sugimoto; H Mizusawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-08       Impact factor: 10.154

Review 9.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

10.  Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.

Authors:  Manja Reimann; Claudia Schmidt; Birgit Herting; Silke Prieur; Susann Junghanns; Katherine Schweitzer; Christoph Globas; Ludger Schoels; Heinz Reichmann; Daniela Berg; Tjalf Ziemssen
Journal:  J Neural Transm (Vienna)       Date:  2009-09-17       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.